Eshwar Pharmaceuticals LLP
About Eshwar Pharmaceuticals LLP
Data last updated:
Eshwar Pharmaceuticals LLP was a limited liability partnership (LLP) based in Hyderabad, Telangana, India. The LLP has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the organic chemicals and compounds segment of the chemicals and materials sector. It was incorporated on 23 April 2019.
The LLP was registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAP-0278.
The LLP had a total obligation of contribution of ₹1.57 Cr. It was led by designated partners Krishna Chaitanya Potluri and Hari Kishore Potluri.
Its latest statement of accounts is for the year ended 31 March 2022. The registered office was at H. No. 8 – 3 – 678/A Pent House Akkruthi Mansion Yellareddy Guda Navodaya Colony, Hyderabad, Telangana, India – 500073.
As per the financials filed for FY 2021, the LLP reported a revenue of ₹15.04 Lakh, a growth of 86% compared to the previous year. For the same year it recorded EBITDA of ₹2.48 Lakh (EBITDA margin 16.5%).
The LLP was associated with 1 brand: Eshwar Pharmaceuticals.
Company details
Contact details
Eshwar Pharmaceuticals LLP's registered office is in Hyderabad, Telangana.
- Registered AddressH. No. 8 – 3 – 678/A Pent House Akkruthi Mansion Yellareddy Guda Navodaya Colony, Hyderabad, Telangana, India – 500073
- IndustryChemicals and Materials, Organic Chemicals & Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eshwar Pharmaceuticals operates one associated brand: Eshwar Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures active pharmaceutical ingredients and intermediates for the healthcare industry. | eshwarpharma.com |
Financials of Eshwar Pharmaceuticals LLP
FY 2022 filings availableEshwar Pharmaceuticals LLP reported revenue of ₹15.04 Lakh (up 86% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 86% in the latest year. EBITDA rose 349% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | ||
| Other Income | ||
| Total Income | ||
| Purchases and Direct Costs | ||
| Personnel Expenses | ||
| Administrative Expenses | ||
| Interest | ||
| Depreciation | ||
| Total Expenses | ||
| Profit Before Tax | ||
| Tax | ||
| Profit After Tax | ||
| Profit Transferred to Partners | ||
| Assets and Liabilities | ||
| Partners' Contribution | ||
| Reserves and Surplus | ||
| Secured Loans | ||
| Unsecured Loans | ||
| Trade Payables | ||
| Other Liabilities and Provisions | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Loans and Advances | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | ||
| Return on Partners' Funds | ||
| Return on Assets | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Debt to Partners' Funds | ||
| Interest Coverage | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Turnover Growth | ||
| Profit Growth | ||
To see the full financial statements and ratios of Eshwar Pharmaceuticals LLP, buy the company report.
Designated partners of Eshwar Pharmaceuticals LLP
Eshwar Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Chaitanya Potluri Also directs: Altuscarbon Private Limited | Designated Partner | 23 Apr 2019 | 7 Years 6 Months | As last reported |
| Hari Kishore Potluri | Designated Partner | 23 Apr 2019 | 7 Years 6 Months | As last reported |
Peer comparison
Eshwar Pharmaceuticals LLP is compared with the 10 companies closest to it by revenue in the Chemicals industry (Formulations, Organic Chemicals, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Carnival Industries Private Limited | ₹15.07 Lakh (FY 2025) | Nagpur, Maharashtra, India | ||||
| Synthecis Pharmaceuticals Private Limited | ₹15.07 Lakh (FY 2025) | 854.0% | Hyderabad, Telangana, India | |||
| Awesome Pharmaceuticals Private Limited | ₹15.06 Lakh (FY 2025) | -71.0% | Lucknow, Uttar Pradesh, India | |||
| Kalysta Pharmaceuticals Private Limited | ₹15.06 Lakh (FY 2018) | Mumbai, Maharashtra, India | ||||
| Dr Velankars the Herbal Shopee Private Limited | ₹15.04 Lakh (FY 2025) | 2.0% | Sangali, Maharashtra, India | |||
| Eshwar Pharmaceuticals LLPthis company | ₹15.04 Lakh (FY 2021) | 86.0% | Hyderabad, Telangana, India | |||
| Stattlich Pharmaceuticals Private Limited | ₹15.03 Lakh (FY 2021) | -8.0% | Amravati, Maharashtra, India | |||
| Epitask Pharmaceuticals Private Limited | ₹15.01 Lakh (FY 2018) | 837.0% | Wavanje, Maharashtra, India | |||
| Nahush Pharmaceuticals Private Limited | ₹15.01 Lakh (FY 2025) | Patna, Bihar, India | ||||
| Dr Mittal Laboratories Private Limited | ₹15 Lakh (FY 2025) | 134.0% | Dehradun, Uttarakhand, India | |||
| United Pharmatech (India) Private Limited | ₹15 Lakh (FY 2024) | 4935.0% | New Delhi, Delhi, India |
To see the full peer comparison of Eshwar Pharmaceuticals LLP, buy the company report.
Legal cases
No court or tribunal cases involving Eshwar Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eshwar Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Eshwar Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Eshwar Pharmaceuticals LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Hari Kishore Potluri was appointed as Designated Partner on 23 Apr 2019.
Frequently asked questions
Eshwar Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the LLP has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off LLP cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Eshwar Pharmaceuticals was a limited liability partnership based in Hyderabad, Telangana, India. The LLP worked in organic chemicals and compounds, within the chemicals and materials industry. It was incorporated on 23 April 2019 and is registered under LLPIN AAP-0278. The LLP has been struck off by the Registrar of Companies and is no longer operational.
Eshwar Pharmaceuticals had 2 designated partners:
- Krishna Chaitanya Potluri - Designated Partner
- Hari Kishore Potluri - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Eshwar Pharmaceuticals is AAP-0278. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
The registered office of Eshwar Pharmaceuticals is at H. No. 8 – 3 – 678A Pent House Akkruthi Mansion Yellareddy Guda Navodaya Colony, Hyderabad, Telangana, India – 500073.
Eshwar Pharmaceuticals was incorporated on 23 April 2019. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Eshwar Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 31 March 2021. Year-wise statements from FY 2020 are in the company report.
Eshwar Pharmaceuticals operated in the chemicals and materials industry, in the organic chemicals and compounds segment. It worked in this industry before it was struck off.
The peers of Eshwar Pharmaceuticals by revenue are Carnival Industries Private Limited, Synthecis Pharmaceuticals Private Limited, Awesome Pharmaceuticals Private Limited, Kalysta Pharmaceuticals Private Limited, Dr Velankars the Herbal Shopee Private Limited and 5 more, all in the Chemicals industry (Formulations, Organic Chemicals, Pharmaceuticals).
Hari Kishore Potluri was appointed as Designated Partner on 23 Apr 2019. Krishna Chaitanya Potluri was appointed as Designated Partner on 23 Apr 2019.
Eshwar Pharmaceuticals has 1 associated brand: Eshwar Pharmaceuticals.